MX4A.STU CME GROUP-A (MX4A.SG)
- Market cap
- -
- P/E
- 25.8x
- P/B
- 4.10x
- ROE
- 16.2%
- Dividend yield
- 2.87%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is MX4A.STU undervalued?
Graham numberThe Graham number of CME GROUP-A (MX4A.SG) cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CME GROUP-A (MX4A.SG) fundamental analysis
No fundamental analysis for CME GROUP-A (MX4A.SG) yet.
CME GROUP-A (MX4A.SG) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
CME GROUP-A (MX4A.SG) financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CME GROUP-A (MX4A.SG) annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 3.60B | 3.64B | 4.31B | 4.87B | 4.88B | 4.69B | 5.02B | 5.58B | 6.13B | 6.52B | 7.10B |
| Gross Profit | 3.03B | 3.06B | 3.64B | 3.97B | 4.03B | 3.85B | 4.27B | 4.75B | 5.28B | 5.61B | 6.18B |
| Operating Income | 2.20B | 2.31B | 2.61B | 2.59B | 2.64B | 2.65B | 3.02B | 3.44B | 3.93B | 4.23B | 4.74B |
| EBITDA | - | 2.85B | 3.18B | 3.34B | 3.35B | 3.93B | 4.02B | 4.67B | 5.04B | 5.83B | 6.10B |
| Net Income | 1.53B | 4.06B | 1.96B | 2.12B | 2.11B | 2.64B | 2.69B | 3.23B | 3.53B | 4.07B | 4.31B |
| EPS | - | 12 | 5.50 | 5.92 | 5.88 | 7.35 | 7.50 | 8.98 | 9.80 | 11 | 12 |
| Balance Sheet | |||||||||||
| Total Assets | 69.4B | 75.8B | 77.5B | 75.2B | 125B | 197B | 174B | 130B | 137B | 198B | 192B |
| Total Liabilities | 49.0B | 53.4B | 51.5B | 49.1B | 98.3B | 169B | 147B | 103B | 111B | 170B | 166B |
| Shareholders' Equity | 20.3B | 22.4B | 25.9B | 26.1B | 26.3B | 27.4B | 26.9B | 26.7B | 26.5B | 28.7B | 26.6B |
| Cash & Short-term Investments | 1.87B | 1.90B | 1.37B | 1.55B | 1.63B | 2.83B | 2.72B | 2.91B | 2.89B | 4.42B | 2.20B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.72B | 1.84B | 2.44B | 2.67B | 2.72B | 2.40B | 3.06B | 3.45B | 3.69B | 4.28B | 4.39B |
| Capital Expenditure | 91.8M | 81.9M | 117M | 246M | 198M | 127M | 89.7M | 76.4M | 94.0M | 83.5M | 81.6M |
| Free Cash Flow | - | 1.76B | 2.32B | 2.43B | 2.52B | 2.28B | 2.97B | 3.38B | 3.60B | 4.19B | 4.31B |
| Ratios | |||||||||||
| ROE | 7.5% | 18.1% | 7.6% | 8.1% | 8.0% | 9.6% | 10.0% | 12.1% | 13.3% | 14.2% | 16.2% |
| ROA | 2.2% | 5.4% | 2.5% | 2.8% | 1.7% | 1.3% | 1.5% | 2.5% | 2.6% | 2.1% | 2.2% |
| Net Profit Margin | 42.7% | 111.5% | 45.5% | 43.5% | 43.1% | 56.2% | 53.6% | 57.8% | 57.5% | 62.5% | 60.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CME GROUP-A (MX4A.SG) dividends
- Dividend yield
- 2.87%
- Forward dividend
- -
- Payout ratio
- 96.6%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 3.93B | 11 | 96.6% |
| 2024 | USD 3.58B | 9.97 | 101.7% |
| 2023 | USD 3.24B | 9.01 | 100.3% |
| 2022 | USD 2.63B | 7.34 | 97.9% |
| 2021 | USD 2.19B | 6.11 | 83.0% |
| 2020 | USD 2.11B | 5.89 | 100.2% |
| 2019 | USD 1.70B | 4.74 | 80.1% |
| 2018 | USD 2.15B | 6.03 | 109.6% |
| 2017 | USD 1.99B | 5.88 | 49.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns CME GROUP-A (MX4A.SG)
Ownership data of CME GROUP-A (MX4A.SG) is not available yet.
CME GROUP-A (MX4A.SG) company profile
- Company name
- CME GROUP-A (MX4A.SG)
- Ticker
- MX4A.STU
- Exchange
- Stuttgart Exchange
- Sector
- Other
- Industry
- Metals & Mining
- Fiscal year end
- December
- Address
- Website
- -
About CME GROUP-A (MX4A.SG)
There is no Profile data available for MX4A.SG.